Clinical Trial Update: Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating physician and parent decisions to treat selective mutism with fluoxetine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Selective Mutism
• Social Anxiety Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Michigan State University | Conditions: Selective Mutism, Social Anxiety | Phase 2 | Status: COMPLETED